Cocrystal Pharma Statistics
NASDAQ: COCPHealthcareBiotechnologyUSD
1.070.00 (0.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Cocrystal Pharma by the numbers
Cocrystal Pharma has a market capitalization of $20.6 million based on 19.26M shares outstanding. With trailing EPS of $-0.76, Cocrystal Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.2% below its 50-day average and 3.2% below its 200-day average.
Average daily trading volume is 56.00K shares, or about $59,924 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
COCP valuation vs. peer median
| Metric | COCP | Peer median | Difference |
|---|---|---|---|
| Market cap | $20.61M | $18.61M | +11% |
| Avg. volume | 56.00K | 130.73K | -57% |
Peer median across 8 companies: QNTM, PLRZ, QNRX, JSPR, AKTX, ICU, ESLA, NEUP.
Valuation
- Market cap
- $20.61M
- EPS (TTM)
- $-0.76
- Shares outstanding
- 19.26M
Price and trading
- Previous close
- 1.07
- Open
- 1.06
- Day range
- 1.06 – 1.10
- 52-week range
- 0.76 – 2.03
- 52-week change
- -14.40%
- Beta
- —
- Volume
- 29.03K
- Average volume
- 56.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2025
Additional statistics
- Market Cap
- 20.61M
- Forward Pe
- -1.84
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.03
- Week52 Low
- 0.76
- Avg Volume
- 56,004.00
- Shares Outstanding
- 19.26M
- Ma50
- 1.12
- Ma200
- 1.11
- Earnings Date
- Aug 13, 2025
- Pct From52w High
- -47.29%
- Pct From52w Low
- 40.79%